328 related articles for article (PubMed ID: 4944203)
1. In vitro susceptibility and resistance of Candida spp. to hamycin.
Athar MA
Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
[No Abstract] [Full Text] [Related]
2. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the activity of the preparation cerbiden against Candida spp].
Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
[TBL] [Abstract][Full Text] [Related]
4. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Batura-Gabryel H; Wieczorek U; Mlynarczyk W
Pneumonol Alergol Pol; 1997; 65(5-6):355-9. PubMed ID: 9340063
[TBL] [Abstract][Full Text] [Related]
5. Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics.
Hamilton-Miller JM
J Med Microbiol; 1972 Nov; 5(4):425-40. PubMed ID: 4566877
[No Abstract] [Full Text] [Related]
6. [On the in vitro sensitivity of Candida albicans to nystatin, trichomycin, amphotericin B and gentian violet].
Simon C; Tabrizi SA
Med Welt; 1967 Sep; 37():2164-8. PubMed ID: 5629382
[No Abstract] [Full Text] [Related]
7. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenic yeasts in clinical examination material. Demonstration, differentiation and sensitivity determination].
Preac-Mursic V
Munch Med Wochenschr; 1972 Sep; 114(35):1520-3. PubMed ID: 4628081
[No Abstract] [Full Text] [Related]
9. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
10. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
Haller I
Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
[No Abstract] [Full Text] [Related]
11. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
12. [The sensitivity of yeasts from the Candida genus isolated from cancer patients to polyene antifungals].
Alves SH; Cury AE
Rev Inst Med Trop Sao Paulo; 1992; 34(3):251-4. PubMed ID: 1342079
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
14. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. [Diffuse chronic mucocutaneous candidiasis: Effects of antimycotics in vitro].
Ottolenghi F; Andreassi L; Sbano E; Fimiani M
Hautarzt; 1975 May; 26(5):260-3. PubMed ID: 1150440
[No Abstract] [Full Text] [Related]
18. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples.
Schmidt A
Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097
[TBL] [Abstract][Full Text] [Related]
20. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
